Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery

Official title: Assessing Delivery Approaches for Prehabilitation Trials in Gynecologic Cancer: A Pilot Feasibility Patient-Preference Trial

Run by Queen's University · NCT07609082 · Data updated 2026-11-12

This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment36 (estimated)
SponsorQueen's University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Kingston, Ontario)
StatusRecruiting
StartedMay 14, 2027
Main results expectedMay 14, 2027
Study endsMay 14, 2027
Registry record updatedOctober 30, 2026
Trial IDNCT07609082 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older scheduled for cytoreductive surgery for a gynecologic mass suspicious or confirmed of cancer, with at least 3 weeks before surgery and able to consent and understand English.

Probably not a fit

Patients who are unable to participate in an exercise program due to health or logistical barriers may not experience direct benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

ADAPT is a single-center pilot trial comparing three prehabilitation delivery models—in-person, remote with coaching and a web app, and education-only—for women preparing for ovarian cancer surgery. The study aims to see if participants can reach at least 10 MET-hours per week of aerobic exercise before surgery and which delivery method patients prefer. It evaluates feasibility, acceptability, and practicality to inform future larger trials, with attention to barriers such as travel and scheduling. The trial also considers how multimodal prehabilitation may influence postoperative recovery by targeting fitness, nutrition, and psychological support. Participants may choose their group or be randomly assigned, and the study is designed to identify the most workable approach for gynecologic cancer patients undergoing cytoreductive surgery.

Why it matters

Potential benefit: If successful, the program could improve patients' fitness and recovery after surgery and guide future care models for gynecologic cancer patients.

How similar studies have gone: Prior studies suggest prehabilitation may improve recovery, but results vary; this trial explores delivery feasibility to optimize future evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female
* Aged ≥18 years
* Scheduled for cytoreductive surgery for a gynecologic mass suspected or confirmed of cancer
* Surgery planned ≥3 weeks from time of booking
* No contraindications to exercise on the CSEP Get Active Questionnaire
* Able to provide written informed consent
* Able to understand and communicate in English

Exclusion Criteria:

* Pregnancy
* Cervical pathologies
* Surgery scheduled \<3 weeks from booking
* Receiving neoadjuvant chemotherapy
* Positive contraindications to exercise on the CSEP Get Active Questionnaire
* End-stage or advanced renal disease limiting safe protein supplementation
* Malnutrition as assessed by a registered dietician

Where it's running

  • Kingston Health Sciences Centre
    Kingston, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.